MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
2015 |
Branche |
Diagnostik & Forschung |
Börse |
NYSESPB |
Anteile |
236 M |
Marktkapitalisierung |
$ 21.2 M |
EBITDA (LTM) |
$ -1.62 B |
P/E (LTM) |
- |
P/S (LTM) |
0.04 |
EPS (LTM) |
-6.24 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
$ 111.16 | -2.04 % | $ 33.8 B | NYSE,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Sotera Health Company
SHC
|
$ 13.26 | -2.07 % | $ 3.77 B | Nasdaq Global Select Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
|
Biodesix
BDSX
|
$ 14.28 | -2.19 % | $ 1.85 B | Nasdaq Global Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
BioNano Genomics
BNGO
|
$ 1.14 | -1.3 % | $ 6.21 M | Nasdaq Capital Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.25 | -12.16 % | $ 175 M | Nasdaq Global Market |  China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.03 | -2.71 % | $ 667 M | Nasdaq Global Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 158.22 | -4.18 % | $ 7.84 B | NYSE,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 196.67 | -0.75 % | $ 21.8 B | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 8.45 | - | $ 33.7 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 62.38 | -5.61 % | $ 24.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 15.72 | -4.06 % | $ 475 M | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 84.78 | -3.77 % | $ 10.6 B | Nasdaq Global Select Market,SPB | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 102.7 | -0.37 % | $ 8.47 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 118.42 | -4.81 % | $ 18.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.68 | -2.89 % | $ 7.37 M | Nasdaq Global Select Market | USA |
 |
IQVIA Holdings
IQV
|
$ 165.13 | -2.52 % | $ 28.4 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 74.66 | -2.23 % | $ 5.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Medpace Holdings
MEDP
|
$ 455.39 | -2.4 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 240.08 | -2.36 % | $ 25.6 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 4.43 | -4.22 % | $ 410 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.7 | 2.4 % | $ 2.52 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 7.55 | -2.77 % | $ 967 M | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 8.85 | -3.33 % | $ 1.92 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.23 | -0.78 % | $ 386 M | Nasdaq Global Select Market | USA |
 |
Celcuity
CELC
|
$ 108.87 | -5.06 % | $ 5.09 B | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |